Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
Hull M, Sadowsky C, Arai H, Le Prince Leterme G, Holstein A, Booth K, Peng Y, Yoshiyama T, Suzuki H, Ketter N, Liu E, Ryan JM.
Hull M, et al. Among authors: yoshiyama t.
Curr Alzheimer Res. 2017;14(7):696-708. doi: 10.2174/1567205014666170117101537.
Curr Alzheimer Res. 2017.
PMID: 28124589
Free PMC article.
Clinical Trial.